Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome

Pulmonary fibrosis (PF) is a chronic lung disorder characterized by the presence of scarred and thickened lung tissues. Although the Food and Drug Administration approved two antifibrotic drugs, pirfenidone, and nintedanib, that are currently utilized for treating idiopathic PF (IPF), the clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yu-Hsin, Chen, I-Chen, Li, Wan-Chun, Hsu, Jong-Hau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341703/
https://www.ncbi.nlm.nih.gov/pubmed/37446052
http://dx.doi.org/10.3390/ijms241310876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341703/
https://www.ncbi.nlm.nih.gov/pubmed/37446052
http://dx.doi.org/10.3390/ijms241310876

Ejemplares similares